English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/56300
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Effect of a Mediterranean Diet Supplemented With Nuts on Metabolic Syndrome Status One-Year Results of the PREDIMED Randomized Trial

AuthorsSalas-Salvadó, Jordi; Fernández-Ballart, Joan; Ros, Emilio; Martínez-González, Miguel A.; Fitó, Montserrat; Estruch, Ramón; Corella, Dolores; Fiol, Miquel; Gómez-Gracia, Enrique; Arós, Fernando; Flores, Gema ; Lapetra, José; Lamuela-Raventós, Rosa M.; Ruiz-Gutiérrez, Valentina ; Bulló, Mònica; Basora, Josep; Covas, María Isabel
Issue Date8-Dec-2008
PublisherAmerican Medical Association
CitationArchives of Internal Medicine 168(22): 2449-2458 (2008)
AbstractBackground Epidemiological studies suggest that the Mediterranean diet (MedDiet) may reduce the risk of developing the metabolic syndrome (MetS). We compared the 1-year effect of 2 behavioral interventions to implement the MedDiet vs advice on a low-fat diet on MetS status. Methods A total of 1224 participants were recruited from the PREDIMED (Prevención con Dieta Mediterránea) Study, a multicenter, 3-arm, randomized clinical trial to determine the efficacy of the MedDiet on the primary prevention of cardiovascular disease. Participants were older subjects at high risk for cardiovascular disease. Interventions were quarterly education about the MedDiet plus provision of either 1 L/wk of virgin olive oil (MedDiet + VOO) or 30 g/d of mixed nuts (MedDiet + nuts), and advice on a low-fat diet (control diet). All diets were ad libitum, and there was no increase in physical activity for any of the interventions. Lifestyle variables and MetS features as defined by the National Cholesterol Education Program Adult Treatment Panel III criteria were assessed. Results At baseline, 61.4% of participants met criteria for the MetS. One-year prevalence was reduced by 6.7%, 13.7%, and 2.0% in the MedDiet + VOO, MedDiet + nuts, and control diet groups, respectively (MedDiet + nuts vs control groups, P = .01; MedDiet + VOO vs control group, P = .18). Incident rates of the MetS were not significantly different among groups (22.9%, 17.9%, and 23.4%, respectively). After adjustment for sex, age, baseline obesity status, and weight changes, the odds ratios for reversion of MetS were 1.3 (95% confidence interval, 0.8-2.1) for the MedDiet + VOO group and 1.7 (1.1-2.6) for the MedDiet + nuts group compared with the control diet group. Conclusion A traditional MedDiet enriched with nuts could be a useful tool in the management of the MetS.
Publisher version (URL)http://dx.doi.org/10.1001/archinte.168.22.2449
URIhttp://hdl.handle.net/10261/56300
DOI10.1001/archinte.168.22.2449
ISSN0003-9926
Appears in Collections:(IG) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.